Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Can low total IgG indicate impaired humoral immune capacity even when some antibodies are still detectable?

Low total IgG can indicate impaired humoral immune capacity even if selected antibody clones remain detectable.

PlausibleSeptember 23, 20266 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Low total IgG can indicate impaired humoral immune capacity even when selected antigen-specific or autoreactive antibody clones remain detectable.

laying out figure…
0 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says that a reduced total IgG level can still reflect weaker antibody-mediated protection, even when some antigen-specific or autoreactive antibodies are measurable. The mechanism framing shows that persistent individual antibody clones may be maintained separately from broad polyclonal IgG production, so a positive specific antibody test does not rule out overall humoral deficiency. It also notes that low IgG can arise from reduced production, increased loss, or increased catabolism.

Verified conclusion

Low total IgG is clinically relevant because it can signal reduced antibody-mediated protection, even when individual antibody tests remain positive. In a 77-year-old, interpretation should account for persistence, severity, infections, vaccine responsiveness, and potential secondary causes.

Clinical significance

  • Persistent, especially severe, hypogammaglobulinemia is associated with impaired humoral immune capacity and greater risk of serious bacterial infections. In adults with primary hypogammaglobulinemia, IgG concentrations below approximately 3–4 g/L correlate with pneumonia and serious bacterial-infection risk; persistent IgG below 1 g/L denotes particularly high risk.
  • Total IgG is an indicator rather than a complete functional test. Repeat quantitative immunoglobulins, infection history, and antibody responses to protein and polysaccharide vaccines provide a more clinically meaningful assessment.

Why positive individual antibodies can coexist with low IgG

  • Detectable antibodies against selected pathogens do not establish intact global antibody production or the ability to mount new, broad, durable responses.
  • Long-lived plasma cells generated during prior germinal-center responses can persist in bone-marrow survival niches and secrete a particular antigen-specific antibody for years to decades, despite impaired new B-cell responses or reduced polyclonal IgG production.
  • The same principle applies to autoreactive antibodies: autoreactive long-lived plasma cells may remain detectable and relatively resistant to B-cell depletion. FcRn-mediated IgG recycling further prolongs circulating IgG survival.

Mechanistic and clinical considerations

  • Low IgG can result from reduced production, but increased immunoglobulin loss or catabolism can also produce hypogammaglobulinemia.
  • Evaluation should consider secondary contributors, including protein loss, medications, malignancy, nutritional factors, and systemic disease.

Bottom line

  • Low total IgG supports possible impaired humoral immunity; retained antigen-specific titers or autoantibodies are compatible with, and do not rule out, clinically meaningful antibody deficiency.

References

  1. Frontiers | The Natural History of Untreated Primary Hypogammaglobulinemia in Adults: Implications for the Diagnosis and Treatment of Common Variable Immunodeficiency Disorders (CVID) — frontiersin.org ↗
  2. Pathogenesis, Diagnosis, and Management of Primary ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  3. Practical guidance for the diagnosis and management of secondary — aaaai.org ↗
  4. Molecular and cellular mechanisms underlying defective ... — onlinelibrary.wiley.com ↗
  5. Mechanisms of Autoantibody-Induced Pathology - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  6. Clinical Consequences of Defects in B cell Development - PMC — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Unsupported4 sourcesDoes a positive Anaplasma IgM alone diagnose active anaplasmosis?→Plausible13 sourcesCan gliotoxin and mycophenolic acid alter immune processes without proving neural autoimmunity?→